Navigation Links
Consumer Reports to Parents: Think Twice About Free Prescription ADHD Drug Samples for Your Children
Date:7/8/2009

Consumers Could Save Roughly $3,000 A Year By Switching From Expensive Brand Name Drugs to Equally Effective Generics To Treat Attention Deficit Hyperactivity Disorder (ADHD)

YONKERS, N.Y., July 8 /PRNewswire-USNewswire/ -- According to a new Consumer Reports Best Buy Drugs report, parents should be skeptical if their doctors offer them free prescription drug samples, especially for the treatment of attention deficit hyperactivity disorder (ADHD). Free samples can hook consumers on high-priced brand name drugs that are not any better or safer than less expensive generic medicines. In addition, when doctors give out free samples, they often fail to give patients information inserts that highlight important safety and side effect information.

Consumer Reports Best Buy Drugs found that two generic ADHD drugs, dextroamphetamine and methylphenidate, are as safe and effective as well- known drugs like Adderall XR, Concerta or Strattera. By switching to one of those two generic drugs, consumers could save roughly $3,000 a year off the retail price. The report is available for free online at www.ConsumerReportsHealth.org/BestBuyDrugs.

"Parents want to do what is best for their children," says Dr. John Santa, director of the Consumer Reports Health Ratings Center. "But free samples and clever advertising convince them they should be shelling out thousands of dollars a year for brand name prescription drugs when equally effective generics are available."

ADHD is one of the most common behavioral problems diagnosed among school-age children in the United States and about 7 percent (about 4.5 million in 2006) of children aged 4 to 17 have been diagnosed with the disorder. When ADHD needs to be treated with medication, parents may be presented with advertisements and free samples of expensive brand-name drugs.

Drug companies gave away an estimated $16 billion in free drug samples in 2004, and doctors routinely hand out these free samples to parents. In fact, according to one October 2008 study in the journal of Pediatrics; about 1 out of every 10 kids already taking a medication got a free drug sample. According to that study, which looked at data from 2004, the ADHD drug Strattera was the 4th most common free drug sample given to children; Adderall XR was in the top 15.

A recent poll by the Consumer Reports National Research Center revealed that 80 percent of Americans who take prescription drugs have received free samples from their physicians. "The use of free samples is extremely prevalent and insidious," said Santa. "And is likely not the best first-choice treatment for a patient's condition."

"Once the samples run out, consumers are likely to end up with sticker shock when they go to fill the prescription," explained Santa. Moreover, samples often do not contain a patient package insert, which describe important safety information.

Ensure a Correct ADHD Diagnosis

Consumer Reports Best Buy Drugs notes that many young patients who take ADHD drugs either do not have ADHD or have only mild symptoms. Before starting any drug treatment for ADHD, it's essential to get an accurate diagnosis by a medical professional.

"Few children present with symptoms of ADHD that can be easily diagnosed by simple observation," said Dr. Orly Avitzur, medical adviser, Consumers Union. "Most need to be evaluated with formal testing, and questionnaires answered by the parents and teachers. A complete history and physical examination should also be performed before medication is prescribed."

Children or teens with ADHD exhibit a persistent pattern, lasting six months or more, including impulsive behavior, hyperactivity, and/or lack of focus and inability to complete a task. A pediatrician, primary care doctor or mental-health professional should always begin by ruling out other possible reasons for their behavior. Parents should question a medical professional who diagnoses ADHD on the first visit and prescribes a drug on the spot.

ADHD Drugs May Only Work for a Few Years

And there is another hitch: a recent study shows that at least one ADHD stimulant drug, methylphenidate (Ritalin), may only work for a few years. There is little evidence proving a clear benefit beyond that. Long term studies have not been done on other ADHD drugs. Parents should routinely check in with their child's doctor about whether the drugs are still working since all stimulant drugs, along with Strattera (a non-stimulant), may have long-term risks, including possibly suppressing a child's growth and a rare risk of sudden death, stroke or heart attack.

Methodology

The Consumer Reports Best Buy Drugs report on drugs to treat ADHD is based on a systematic review of hundreds of research articles and studies, where the risks and benefits of one drug or many drugs against each other are evaluated. This kind of systematic review is known as comparative effectiveness and all Consumer Reports Best Buy Drugs reports use this process as the basis for their drug Ratings.

Find out more about the Consumer Reports Best Buy Drugs program that evaluates more than 200 drugs for dozens of common conditions here: www.ConsumerReportsHealth.org/Best-Buy-Drugs.

JULY 2009

(C) Consumers Union 2009. The material above is intended for legitimate news entities only; it may not be used for commercial or promotional purposes. Consumer Reports(R) is published by Consumers Union, an expert, independent nonprofit organization whose mission is to work for a fair, just, and safe marketplace for all consumers and to empower consumers to protect themselves. To achieve this mission, we test, inform, and protect. To maintain our independence and impartiality, Consumers Union accepts no outside advertising, no free test samples, and has no agenda other than the interests of consumers. Consumers Union supports itself through the sale of our information products and services, individual contributions, and a few noncommercial grants.


'/>"/>
SOURCE Consumer Reports Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sokolove Law Launches Chinese Drywall Consumer Advocacy Hotline
2. European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe
3. Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online, Interactive Dashboards for Cancer Patients
4. Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China
5. Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers
6. Alpharmas Reach Teach Learn Initiative Targets Youth and Consumer Awareness
7. Bausch & Lomb Kicks Off U.S. Consumer Online Marketing Campaign for SofLens(R) Daily Disposable Contact Lenses
8. Federal Trade Commission Reports: Authorized Generics, During the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
9. Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care
10. Consumers Can Now Shop Online for Individual Health Insurance Coverage With Mercy Health Plans
11. New Online Company Is Helping to Bring a Solution to the Increasingly Devastating Problem of Healthcare Costs in America, at No Cost to Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: